Plus Therapeutics Announces Key Opinion Leader Roundtable on New Clinical Trial Data Being Presented at the 2023 SNO/ASCO CNS Cancer Conference

Trial investigators and company management to discuss latest data from the ReSPECT-LM leptomeningeal metastases clinical trial Webinar scheduled for Friday, August 11, 2023 at 8:00 a.m. ET AUSTIN,...

Related Keywords

San Antonio ,Texas ,United States ,University Of Texas ,American ,Peter Vozzo ,Priya Kumthekar ,Justin Walsh ,March Hedrick ,Andrewj Brenner ,Terri Clevenger ,Exchange Commission ,Globenewswire Inc ,American Society Of Clinical Oncology ,Nasdaq ,Northwestern University ,Feinberg School Of Medicine ,Society For Neuro Oncology ,Health Services Center ,Jones Research ,Therapeutics Inc ,Neuro Oncology ,Clinical Oncology ,Central Nervous System ,Cancer Conference ,Associate Professor ,Chief Executive Officer ,Healthcare Analyst ,Investor Relations ,For Investor ,Markets ,